UCL70805F

· UTC Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UCL70805F, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: UCL70805F in Patients With CD70-positive Advanced Renal Clear Cell Carcinoma [Phase 1]